financetom
Business
financetom
/
Business
/
Doximity Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Doximity Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing
Aug 12, 2024 12:56 AM

03:41 AM EDT, 08/12/2024 (MT Newswires) -- Anna Bryson, Chief Financial Officer, on August 08, 2024, sold 30,000 shares in Doximity ( DOCS ) for $1,050,000. Following the Form 4 filing with the SEC, Bryson has control over a total of 309,627 shares of the company, with 309,627 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1516513/000151651324000066/xslF345X03/wk-form4_1723241043.xml

Price: 35.58, Change: -0.02, Percent Change: -0.06

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Brazil development bank signs deal with AIIB for nearly $3 billion in investments
Brazil development bank signs deal with AIIB for nearly $3 billion in investments
Nov 19, 2024
(Reuters) - Brazilian development bank BNDES said on Monday that it has signed a deal with the Asian Infrastructure Investment Bank (AIIB) for the investment of 16.7 billion reais ($2.89 billion) in Latin America's largest economy. The deal, which was signed on the sidelines of the G20 summit in Rio de Janeiro, is aimed at funding projects aligned with Brazil's...
US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug
US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug
Nov 19, 2024
* Lower court found Norwich generic infringes Salix patents * Alvogen has Xifaxan generic deals with Teva, Sun, Sandoz By Blake Brittain WASHINGTON, Nov 18 (Reuters) - The U.S. Supreme Court turned away on Monday a bid by Alvogen's subsidiary Norwich Pharmaceuticals to sell a generic version of Canada-based Bausch Health's ( BHC ) blockbuster diarrhea drug Xifaxan. The justices...
--Trump Team Looking to Ease Rules on Self-Driving Cars, Bloomberg Reports
--Trump Team Looking to Ease Rules on Self-Driving Cars, Bloomberg Reports
Nov 19, 2024
09:40 AM EST, 11/18/2024 (MT Newswires) -- Price: 343.84, Change: +23.12, Percent Change: +7.21 ...
Tesla Stock Is Trading Higher Monday: What's Going On?
Tesla Stock Is Trading Higher Monday: What's Going On?
Nov 19, 2024
Tesla Inc ( TSLA ) shares are racing higher Monday morning following reports that President-elect Donald Trump plans to ease restrictions for self-driving vehicles. What To Know: Members of Trump’s transition team have said they plan to prioritize a federal framework for autonomous vehicles, according to Bloomberg. The report indicates that the Transportation Department can issue rules through the National...
Copyright 2023-2026 - www.financetom.com All Rights Reserved